WASHINGTON--(BUSINESS WIRE)--Jim Greenwood, president and CEO of the Biotechnology Industry Organization (BIO), issued the following statement on the report entitled, “Bending the Curve: Options for Achieving Savings and Improving Value in U.S. Health Spending” which was recently released by the Commonwealth Fund’s Commission on a High Performance Health System:
